“…The hemagglutination titer decreases with trypsin treatment, and, conversely, infectivity increases. In contrast, the hemagglutinating activity of simian and bovine rotaviruses is not affected by trypsin treatment [Fauvel et al, 1978;Inaba et al, 1977;Kalica et al, 19781. Genetic studies of animal rotavirus reassortants, for example, that of simian (RRV) and bovine (UK) rotaviruses which respectively have and do not have hemagglutinin (HA), have revealed that the HA of simian viruses is the fourth gene product, an 82,000 molecular weight (MW) protein [Kalica et al, 19831. Interestingly, monoclonal antibodies directed against the HA of RRV inhibit hemagglutination but also neutralize infectivity [Greenberg et al, 19831.…”